1. Home
  2. EE vs LXRX Comparison

EE vs LXRX Comparison

Compare EE & LXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Excelerate Energy Inc.

EE

Excelerate Energy Inc.

HOLD

Current Price

$39.35

Market Cap

1.2B

Sector

Utilities

ML Signal

HOLD

LXRX

Lexicon Pharmaceuticals Inc.

HOLD

Current Price

$2.30

Market Cap

990.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EE
LXRX
Founded
2003
1995
Country
United States
United States
Employees
N/A
N/A
Industry
Oil/Gas Transmission
Biotechnology: Pharmaceutical Preparations
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
990.6M
IPO Year
2022
2000

Fundamental Metrics

Financial Performance
Metric
EE
LXRX
Price
$39.35
$2.30
Analyst Decision
Buy
Strong Buy
Analyst Count
5
2
Target Price
$39.20
$4.15
AVG Volume (30 Days)
324.2K
2.8M
Earning Date
05-06-2026
05-01-2026
Dividend Yield
0.96%
N/A
EPS Growth
0.79
77.78
EPS
0.75
N/A
Revenue
$1,228,263,000.00
$49,803,000.00
Revenue This Year
$23.59
N/A
Revenue Next Year
$24.37
N/A
P/E Ratio
$52.48
N/A
Revenue Growth
44.26
60.24
52 Week Low
$23.23
$1.03
52 Week High
$43.18
$2.68

Technical Indicators

Market Signals
Indicator
EE
LXRX
Relative Strength Index (RSI) 61.62 48.99
Support Level $32.03 $2.05
Resistance Level $40.00 $2.50
Average True Range (ATR) 1.47 0.16
MACD 0.27 -0.02
Stochastic Oscillator 89.59 61.61

Price Performance

Historical Comparison
EE
LXRX

About EE Excelerate Energy Inc.

Excelerate Energy Inc. offers comprehensive LNG solutions by providing integrated services throughout the LNG value chain. The company delivers a full range of regasification services, including Floating Storage and Regasification Units (FSRUs), infrastructure development, and the supply of LNG and natural gas. With operational presence in several countries - Argentina, Bangladesh, Brazil, Finland, Germany, Pakistan, the United Arab Emirates (UAE), and the United States. The company generates revenue through Terminal Services, as well as from LNG, gas, and power. These revenues are derived from its vertically integrated activities in LNG sourcing, transportation, regasification, and power generation.

About LXRX Lexicon Pharmaceuticals Inc.

Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, and LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.

Share on Social Networks: